These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 194927

  • 61. Demonstration of hepatitis B surface antigen by orcein staining in paraffin sections of cirrhotic liver.
    Bartók I, Remenár E, Tóth J.
    Virchows Arch A Pathol Anat Histol; 1976 Feb 16; 369(3):239-48. PubMed ID: 56804
    [Abstract] [Full Text] [Related]

  • 62. Cirrhosis and the aetiology of hepatocellular carcinoma.
    Johnson PJ, Williams R.
    J Hepatol; 1987 Feb 16; 4(1):140-7. PubMed ID: 3033058
    [No Abstract] [Full Text] [Related]

  • 63. [alpha 1-antitrypsin deficiency and liver diseases].
    von Schönfeld J, Breuer N.
    Dtsch Med Wochenschr; 1993 Dec 10; 118(49):1819-24. PubMed ID: 8253047
    [No Abstract] [Full Text] [Related]

  • 64. Hepatocellular carcinoma in a rural population at risk.
    Jaskiewicz K, Stepien A, Banach L.
    Anticancer Res; 1991 Dec 10; 11(6):2187-9. PubMed ID: 1663722
    [Abstract] [Full Text] [Related]

  • 65. Hepatic cancer in Chinese: a chapter in "georgraphic pathology".
    Wellmann KF, Vemula NR, Gerstmann KE.
    Am J Chin Med; 1980 Dec 10; 8(1-2):1-16. PubMed ID: 6249113
    [No Abstract] [Full Text] [Related]

  • 66. Does a portal-systemic shunt increase the risk of primary hepatic carcinoma in cirrhosis of the liver?
    Bjørneboe M, Andersen JR, Christensen U, Skinhøj P, Jensen OM.
    Scand J Gastroenterol; 1985 Jan 10; 20(1):59-64. PubMed ID: 3992164
    [Abstract] [Full Text] [Related]

  • 67. Hepatic fibrosis and carcinogenesis in α1-antitrypsin deficiency: a prototype for chronic tissue damage in gain-of-function disorders.
    Perlmutter DH, Silverman GA.
    Cold Spring Harb Perspect Biol; 2011 Mar 01; 3(3):. PubMed ID: 21421920
    [Abstract] [Full Text] [Related]

  • 68. Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor.
    Teitelbaum DH, Tuttle S, Carey LC, Clausen KP.
    Ann Surg; 1985 Jul 01; 202(1):36-41. PubMed ID: 2409935
    [Abstract] [Full Text] [Related]

  • 69. Cirrhotic controls in a pooled analysis of hepatitis D and hepatocellular carcinoma.
    Argirion I, Mahale P, Pfeiffer RM, Koshiol J, O'Brien TR.
    J Hepatol; 2020 Dec 01; 73(6):1583-1584. PubMed ID: 32962868
    [No Abstract] [Full Text] [Related]

  • 70. Alpha-I-antitrypsin and copper in the liver.
    Callea F, Ray MB, Desmet VJ.
    Histopathology; 1981 Jul 01; 5(4):415-24. PubMed ID: 6974127
    [Abstract] [Full Text] [Related]

  • 71. Copper and copper-binding protein in fibrolamellar liver cell carcinoma.
    Lefkowitch JH, Muschel R, Price JB, Marboe C, Braunhut S.
    Cancer; 1983 Jan 01; 51(1):97-100. PubMed ID: 6185196
    [Abstract] [Full Text] [Related]

  • 72. Advanced hepatocellular carcinoma associated with cystic fibrosis.
    Kelleher T, Staunton M, O'Mahony S, McCormick PA.
    Eur J Gastroenterol Hepatol; 2005 Oct 01; 17(10):1123-4. PubMed ID: 16148560
    [Abstract] [Full Text] [Related]

  • 73. [A case report of resected hepatocellular carcinoma after renal transplantation in a HBsAg positive patient].
    Suenaga M, Kanoh T, Tagami K, Nonami T, Nakao A, Horisawa M, Kondoh T.
    Nihon Shokakibyo Gakkai Zasshi; 1985 Jan 01; 82(1):123-7. PubMed ID: 2985847
    [No Abstract] [Full Text] [Related]

  • 74. Does the Z gene variant of alpha-1-antitrypsin predispose to hepatic carcinoma?
    Reintoft I, Hägerstrand IE.
    Hum Pathol; 1979 Jul 01; 10(4):419-24. PubMed ID: 223964
    [Abstract] [Full Text] [Related]

  • 75. The development of hepatocellular carcinoma in cirrhotic and noncirrhotic livers.
    Morris SA.
    Am J Clin Pathol; 1997 Feb 01; 107(2):251. PubMed ID: 9024075
    [No Abstract] [Full Text] [Related]

  • 76. Chronic liver inflammation and hepatocellular carcinoma: persistence matters.
    Weber A, Boege Y, Reisinger F, Heikenwälder M.
    Swiss Med Wkly; 2011 Feb 01; 141():w13197. PubMed ID: 21557112
    [Abstract] [Full Text] [Related]

  • 77. Regression of Hepatic Fibrosis and Evolution of Cirrhosis: A Concise Review.
    Khan S, Saxena R.
    Adv Anat Pathol; 2021 Nov 01; 28(6):408-414. PubMed ID: 34326286
    [Abstract] [Full Text] [Related]

  • 78. Battling IL-17, the troublemaker in alcohol-induced hepatocellular carcinoma.
    Bansal R.
    J Hepatol; 2020 May 01; 72(5):809-812. PubMed ID: 32122724
    [No Abstract] [Full Text] [Related]

  • 79. Neoplasms, cirrhosis, and hepatic metastases.
    NORKIN SA, HEIMANN R, FAHIMI HD.
    Cancer; 1962 May 01; 15():1004-8. PubMed ID: 14480340
    [No Abstract] [Full Text] [Related]

  • 80. Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in hong kong: a necropsy study: 1963-1976.
    Gibson JB, Wu PC, Ho JC, Lauder IJ.
    Br J Cancer; 1980 Sep 01; 42(3):370-7. PubMed ID: 6252929
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.